PT  - JOURNAL ARTICLE
AU  - Sudipta Saha
AU  - Justin M. Feldman
TI  - Neighborhood-level Racial/Ethnic and Economic Inequities in COVID-19 Burden Within Urban Areas in the US and Canada
AID  - 10.1101/2020.12.07.20241018
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.07.20241018
4099  - http://medrxiv.org/content/early/2020/12/09/2020.12.07.20241018.short
4100  - http://medrxiv.org/content/early/2020/12/09/2020.12.07.20241018.full
AB  - The COVID-19 pandemic exhibits stark social inequities in infection and mortality outcomes. We investigated neighborhood-level inequities across cities in the US and Canada for COVID-19 cumulative case rates (46 cities), death rates (12 cities), testing rates and test positivity (12 cities), using measures that characterize social gradients by race/ethnicity, socioeconomic composition, or both jointly. We found consistent evidence of social gradients for case, death and positivity rates, with the most privileged neighborhoods having the lowest rates, but no meaningful variation in the magnitude of inequities between cities. Gradients were not apparent in testing rates, suggesting inadequate testing in the most deprived neighborhoods. Health agencies should monitor and compare inequities as part of their COVID-19 reporting practices and to guide pandemic response efforts.HIGHLIGHTSWithin urban regions with available data in the US and Canada, there were strong social gradients for case, death and positivity ratesThe most racially and/or economically privileged neighborhoods had the lowest ratesSocial gradients were similar for neighborhood-level measures of racial/ethnic composition, income, racialized economic segregation, and racialized occupational segregationTesting rates did not show consistent social gradients, which suggests that the most deprived neighborhoods have inadequate access to testing relative to their higher disease burdenCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe study received no external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Neither approval nor exemption by an IRB/REB was required because the study only used public-use data that does not allow identification of individuals.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData, code, and additional visualizations available at: https://ssaha.shinyapps.io/COVID_cities_inequities https://ssaha.shinyapps.io/COVID_cities_inequities